Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

The global vulvodynia treatment market is poised for significant growth, with sales expected to rise from USD 6.7 billion in 2025 to USD 12.4 billion by 2035, reflecting a CAGR of 6.3% over the ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

Your go-to for B2B Marketing Training and Consulting backed by data science, psychology, and—our secret weapon—real-world experience. Join 350,000+ marketers who rely on MarketingProfs for B2B ...

Highlights,Klaviyo's market cap stands at $12.95 billion, with a 50-day moving average price of $41.30.,Recent earnings show ...

What’s Behind Sandstorm Gold’s Recent Financial Struggles?

Herpes Labialis Treatment Market. The global herpes labialis treatment market is on track for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 4.7% from ...